No increased cardiovascular risk detected for new diabetes medication
An international, multidisciplinary team including investigators from Brigham and Women's Hospital (BWH) has found that lixisenatide, a member of a class of glucose-lowering drugs frequently prescribed in Europe to patients ...
Jun 8, 2015
0
7